Coronavirus: Newly designed blood test could diagnose carriers before they become infectious, report says

Research has potential to be 'absolutely a gamechanger'

Louise Hall
Friday 01 May 2020 20:17
Comments
Bill Gates says we could see early results from coronavirus vaccine trials this summer

A new coronavirus test designed by US Military scientists may be able to identify virus carriers before they are infectious, according to an exclusive report by The Guardian.

Scientists reportedly hope that the blood-based test could detect the virus’s presence as early as 24 hours after infection, four days earlier than current tests, meaning the carrier could possibly be isolated before they spread the disease.

The research has emerged from a project set up by the US military’s Defence Advanced Research Projects Agency (Darpa) and while the test could significantly help control outbreaks of the disease, it must first be approved by the US Food and Drug Administration (FDA).

If given FDA approval, Dr Brad Ringeisen who is head of Darpa’s biological technologies office told the outlet that the test has the potential to be “absolutely a gamechanger”.

“The concept fills a diagnostic gap worldwide,” the head of Darpa’s biological technologies office, Mr Ringeisen told The Guardian.

The blood test hunts for an RNA molecule that emerges as an immune response to the virus, using the same polymerase chain reaction machines used for checking nasal swabs.

“Because the immune response to infection develops immediately after infection, a Covid signature is expected to provide more sensitive Covid infection diagnosis earlier,” Professor Stuart Sealfon, who leads the research team at Mount Sinai hospital in New York told the newspaper.

“It’s a simple tweak,” said Dr Eric Van Gieson, who redirected his epigenetic characterization and observation programme to focus on Covid-19. “The infrastructure is already there.”

However, predictions that the test might be able to pick up carriers before they become infectious is as of yet only based on previous parallel research into other viruses.

Darpa warned that It won't be practically clear exactly how early the test can pick up the virus until the emergency approval is granted and they can begin to gather evidence.

The test is reported to be submitted for evaluation of emergency use approval (EUA) by the US Food FDA in the next week.

If EUA is granted, the test could reportedly start being utilised in the US later in May, but this approval is not guaranteed.

The research behind the development of the tests will eventually be made public, but until this point, many researchers were unwilling to comment further on the research.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in